Literature DB >> 30132346

Deletion of the formin Diaph1 protects from structural and functional abnormalities in the murine diabetic kidney.

Michaele B Manigrasso1, Richard A Friedman2, Ravichandran Ramasamy1, Vivette D'Agati3, Ann Marie Schmidt1.   

Abstract

Diaphanous 1 (DIAPH1), a member of the formin family, binds to the cytoplasmic domain of the receptor for advanced glycation end products (RAGE) and is required for RAGE signal transduction. Experiments employing genetic overexpression or deletion of Ager (the gene encoding RAGE) or its pharmacological antagonism implicate RAGE in the pathogenesis of diabetes-associated nephropathy. We hypothesized that DIAPH1 contributes to pathological and functional derangements in the kidneys of diabetic mice. We show that DIAPH1 is expressed in the human and murine diabetic kidney, at least in part in the tubulointerstitium and glomerular epithelial cells or podocytes. To test the premise that DIAPH1 is linked to diabetes-associated derangements in the kidney, we rendered male mice globally devoid of Diaph1 ( Diaph1-/-) or wild-type controls (C57BL/6 background) diabetic with streptozotocin. Control mice received equal volumes of citrate buffer. After 6 mo of hyperglycemia, diabetic Diaph1-/- mice displayed significantly reduced mesangial sclerosis, podocyte effacement, glomerular basement thickening, and urinary albumin-to-creatinine ratio compared with diabetic mice expressing Diaph1. Analysis of whole kidney cortex revealed that deletion of Diaph1 in diabetic mice significantly reduced expression of genes linked to fibrosis and inflammation. In glomerular isolates, expression of two genes linked to podocyte stress, growth arrest-specific 1 ( Gas1) and cluster of differentiation 36 ( Cd36), was significantly attenuated in diabetic Diaph1-/- mice compared with controls, in parallel with significantly higher levels of nestin (Nes) mRNA, a podocyte marker. Collectively, these data implicate DIAPH1 in the pathogenesis of diabetes-associated nephropathy and suggest that the RAGE-DIAPH1 axis is a logical target for therapeutic intervention in this disorder.

Entities:  

Keywords:  DIAPH1; RAGE; glycation; kidney; podocyte

Mesh:

Substances:

Year:  2018        PMID: 30132346      PMCID: PMC6336994          DOI: 10.1152/ajprenal.00075.2018

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  57 in total

1.  Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.

Authors:  M Ashburner; C A Ball; J A Blake; D Botstein; H Butler; J M Cherry; A P Davis; K Dolinski; S S Dwight; J T Eppig; M A Harris; D P Hill; L Issel-Tarver; A Kasarskis; S Lewis; J C Matese; J E Richardson; M Ringwald; G M Rubin; G Sherlock
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

2.  A systems biology approach for pathway level analysis.

Authors:  Sorin Draghici; Purvesh Khatri; Adi Laurentiu Tarca; Kashyap Amin; Arina Done; Calin Voichita; Constantin Georgescu; Roberto Romero
Journal:  Genome Res       Date:  2007-09-04       Impact factor: 9.043

3.  Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes.

Authors:  Greg Tesch; Karly C Sourris; Shaun A Summers; Domenica McCarthy; Micheal S Ward; Danielle J Borg; Linda A Gallo; Amelia K Fotheringham; Allison R Pettit; Felicia Y T Yap; Brooke E Harcourt; Adeline L Y Tan; Joshua Y Kausman; David Nikolic-Paterson; Arthur R Kitching; Josephine M Forbes
Journal:  Diabetologia       Date:  2014-06-24       Impact factor: 10.122

4.  Nestin expression in adult and developing human kidney.

Authors:  Eugenio Bertelli; Marì Regoli; Luciano Fonzi; Rossella Occhini; Susanna Mannucci; Leonardo Ermini; Paolo Toti
Journal:  J Histochem Cytochem       Date:  2007-01-08       Impact factor: 2.479

Review 5.  Targeting inflammation in diabetic kidney disease: early clinical trials.

Authors:  Maria Vanessa Perez-Gomez; Maria Dolores Sanchez-Niño; Ana Belen Sanz; Binbin Zheng; Catalina Martín-Cleary; Marta Ruiz-Ortega; Alberto Ortiz; Beatriz Fernandez-Fernandez
Journal:  Expert Opin Investig Drugs       Date:  2016-06-13       Impact factor: 6.206

6.  Advanced oxidation protein products induce apoptosis in podocytes through induction of endoplasmic reticulum stress.

Authors:  Guang Rong; Xun Tang; Tingting Guo; Na Duan; Yue Wang; Lei Yang; Jun Zhang; Xiujie Liang
Journal:  J Physiol Biochem       Date:  2015-07-22       Impact factor: 4.158

7.  Glucagon-like peptide-1 inhibits the receptor for advanced glycation endproducts to prevent podocyte apoptosis induced by advanced oxidative protein products.

Authors:  Shuang-Shuang Zhang; Zhou Wu; Zhen Zhang; Zhou-Yi Xiong; Hong Chen; Qiao-Bing Huang
Journal:  Biochem Biophys Res Commun       Date:  2016-12-10       Impact factor: 3.575

8.  Activation of the receptor for advanced glycation end products induces nuclear inhibitor of protein phosphatase-1 suppression.

Authors:  Marita Liebisch; Tzvetanka Bondeva; Sybille Franke; Christoph Daniel; Kerstin Amann; Gunter Wolf
Journal:  Kidney Int       Date:  2014-01-29       Impact factor: 10.612

9.  A new method for large scale isolation of kidney glomeruli from mice.

Authors:  Minoru Takemoto; Noomi Asker; Holger Gerhardt; Andrea Lundkvist; Bengt R Johansson; Yasushi Saito; Christer Betsholtz
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

10.  Increased serum endogenous secretory receptor for advanced glycation end-product (esRAGE) levels in type 2 diabetic patients with decreased renal function.

Authors:  Tomohito Gohda; Mitsuo Tanimoto; Ju-Young Moon; Hiromichi Gotoh; Tatsuya Aoki; Masakazu Matsumoto; Terumi Shibata; Isao Ohsawa; Kazuhiko Funabiki; Yasuhiko Tomino
Journal:  Diabetes Res Clin Pract       Date:  2008-06-11       Impact factor: 5.602

View more
  8 in total

1.  FSGS-Causing INF2 Mutation Impairs Cleaved INF2 N-Fragment Functions in Podocytes.

Authors:  Balajikarthick Subramanian; Justin Chun; Chandra Perez-Gill; Paul Yan; Isaac E Stillman; Henry N Higgs; Seth L Alper; Johannes S Schlöndorff; Martin R Pollak
Journal:  J Am Soc Nephrol       Date:  2020-01-10       Impact factor: 10.121

2.  Small-molecule antagonism of the interaction of the RAGE cytoplasmic domain with DIAPH1 reduces diabetic complications in mice.

Authors:  Michaele B Manigrasso; Piul Rabbani; Lander Egaña-Gorroño; Nosirudeen Quadri; Laura Frye; Boyan Zhou; Sergey Reverdatto; Lisa S Ramirez; Stephen Dansereau; Jinhong Pan; Huilin Li; Vivette D D'Agati; Ravichandran Ramasamy; Robert J DeVita; Alexander Shekhtman; Ann Marie Schmidt
Journal:  Sci Transl Med       Date:  2021-11-24       Impact factor: 17.956

Review 3.  The RAGE/DIAPH1 Signaling Axis & Implications for the Pathogenesis of Diabetic Complications.

Authors:  Ravichandran Ramasamy; Alexander Shekhtman; Ann Marie Schmidt
Journal:  Int J Mol Sci       Date:  2022-04-21       Impact factor: 6.208

Review 4.  Formins in Human Disease.

Authors:  Leticia Labat-de-Hoz; Miguel A Alonso
Journal:  Cells       Date:  2021-09-27       Impact factor: 6.600

5.  Plasma Diaphanous Related Formin 1 Levels Are Associated with Altered Glucose Metabolism and Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Case Control Study.

Authors:  Xing Li; Mingyu Liao; Jiaqing Shao; Weixin Li; Liu Shi; Dong Wang; Juan Ni; Qiuyue Shen; Fan Yang; Guiliang Peng; Ling Zhou; Yuling Zhang; Zheng Sun; Hongting Zheng; Min Long
Journal:  Mediators Inflamm       Date:  2022-02-11       Impact factor: 4.711

Review 6.  Oxytocin Dynamics in the Body and Brain Regulated by the Receptor for Advanced Glycation End-Products, CD38, CD157, and Nicotinamide Riboside.

Authors:  Haruhiro Higashida; Kazumi Furuhara; Olga Lopatina; Maria Gerasimenko; Osamu Hori; Tsuyoshi Hattori; Yasuhiko Hayashi; Stanislav M Cherepanov; Anna A Shabalova; Alla B Salmina; Kana Minami; Teruko Yuhi; Chiharu Tsuji; PinYue Fu; Zhongyu Liu; Shuxin Luo; Anpei Zhang; Shigeru Yokoyama; Satoshi Shuto; Mizuki Watanabe; Koichi Fujiwara; Sei-Ichi Munesue; Ai Harashima; Yasuhiko Yamamoto
Journal:  Front Neurosci       Date:  2022-07-07       Impact factor: 5.152

Review 7.  Pathophysiology of RAGE in inflammatory diseases.

Authors:  Hanbing Dong; Yue Zhang; Yu Huang; Hui Deng
Journal:  Front Immunol       Date:  2022-07-29       Impact factor: 8.786

Review 8.  RAGE pathway activation and function in chronic kidney disease and COVID-19.

Authors:  Colleen S Curran; Jeffrey B Kopp
Journal:  Front Med (Lausanne)       Date:  2022-08-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.